TGFB1 and diabetic kidney disease: Several groups reported that AMPK activation was able to reduce mesangial matrix expansion and urinary TGF-β1 level as well as inhibit glomerular collagen and fibronectin accumulation in mouse models of diabetic kidney disease [31,32,33].